The Rare Neurodegenerative Disease Treatment Market is on the cusp of significant transformation, driven by the advent of cutting-edge therapies that promise to enhance patient outcomes. According to forecasts, the market is expected to grow from USD 0.2 billion in 2024 to an impressive USD 0.377 billion by 2035, reflecting a compound annual growth rate (CAGR) of 5.93%. The ongoing development...